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Abstract Natural killer (NK) cells play critical roles in
antiviral immunity. While the importance of effector
mechanisms such as interferons has been demonstrated
through knockout mice, specific mechanisms of how
viruses are recognized and controlled by NK cells are less
well defined. Previous genetic studies have mapped the
resistance genes for murine cytomegalovirus (MCMV),
herpes simplex virus-1 (HSV-1), and ectromelia virus to the
NK gene complex on murine chromosome 6, a region
containing the polymorphic Ly49 and Nkrp1 families.
Genetic resistance to MCMV in C57BL/6 has been
attributed to Ly49H, an activation receptor, through
susceptibility of the recombinant inbred strain BXD-8 that
lacks Ly49h (also known as Klra8) but derived about half
of its genome from its DBA/2 progenitor. However, it
remained possible that epigenetic effects could account for
the MCMV phenotype in BXD-8 mice. Herein, we report
the generation of a novel congenic murine strain, B6.
BXD8-Klra8Cmv1-del/Wum, on the C57BL/6 genetic back-
ground to evaluate the effect of deletion of a single NK
activation receptor, Ly49H. Deletion of Ly49H rendered
mice much more susceptible to MCMV infection. This
increase in susceptibility did not appear to be a result of a
difference in NK cell expansion or interferon-γ (IFN-γ)
production between the C57BL/6 and the B6.BXD8 strains.
On the other hand, the deletion of Ly49h did not otherwise
affect NK cell maturation or Ly49D expression and had no
effect on susceptibility to HSV-1 or ectromelia virus. In
conclusion, Ly49h is necessary for genetic resistance to
MCMV, but not HSV-1 or ectromelia virus.
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Introduction
Natural killer (NK) cells play important roles in innate
immunity, particularly to viruses (French and Yokoyama
2003; Gazit et al. 2006). This is best illustrated by the
clinical course of patients with natural killer cell defects
which are characteristically manifested as recurrent infec-
tions with herpesviruses, such as cytomegalovirus (CMV)
and herpes simplex virus-1 (HSV-1; Biron et al. 1989).
Thus, greater understanding of how natural killer cells
specifically recognize and control viral infections will have
important clinical applications.
Given that CMV viruses are species-specific and that
murine CMV (MCMV) shares significant biologic and
genomic similarity with human CMV, MCMV has been
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used extensively as an animal model for HCMV (Gonczol
et al. 1985; Rawlinson et al. 1997). Several host factors,
both major histocompatibility complex (MHC)-dependent
and MHC-independent, account for MCMV resistance
(Adam et al. 2006; Dighe et al. 2005; Grundy et al. 1981;
Rodriguez et al. 2004; Scalzo et al. 1990). The first
identified MHC-independent resistance gene, Cmv1, was
mapped to distal mouse chromosome 6 in the vicinity of the
NK gene complex (NKC) which encodes receptors
expressed on NK cells (Scalzo et al. 1995). Identification
of the Ly49H activation receptor as the product of the Cmv1
locus was aided by the BXD-8 recombinant inbred (RI)
strain (Brown et al. 2001b; Dokun et al. 2001; Lee et
al. 2001).
Ly49H is a member of the Ly49 family of C-type lectin-
like receptors, which are encoded in the NKC region on
distal mouse chromosome 6. The Ly49 family is extremely
polymorphic, displaying haplotypes with variations in gene
number and allelic polymorphism for each gene (Proteau et
al. 2004; Wilhelm et al. 2002). The significant difference in
viral susceptibility between the resistant C57BL/6 and
susceptible BALB/c has been attributed to the expression
of Ly49H on NK cells in C57BL/6, whereas BALB/c mice
lack the Ly49h gene (Brown et al. 2001a; Lee et al. 2001,
2003). Interestingly, loci for genetic resistance to two other
viruses, HSV-1 and ectromelia virus, an orthopoxvirus,
have also been mapped to the NKC (Brown et al. 2001a;
Delano and Brownstein 1995). Although antibody-blocking
experiments do not support a role for Ly49H in resistance
to these viruses (data not shown), Ly49H has not been
extensively studied in resistance by genetic approaches.
The BXD-8 RI strain arose from the consanguineous
mating between C57BL/6 and DBA/2 progenitor strains for
20 generations. Consequently, half of the genome of this
recombinant inbred strain is derived from the resistant
C57BL/6 progenitor strain, while the other half from the
susceptible DBA/2. BXD-8 mice carried C57BL/6 markers
for distal chromosome 6 flanking the NKC region, but
demonstrated increased susceptibility to MCMV compared
to the C57BL/6 strain. This increased susceptibility has
previously been shown to correlate with the absence of
Ly49H expression by staining with the monoclonal anti-
body 3D10 on BXD-8 NK cells and a selective deletion in
Ly49h by Southern analysis (Brown et al. 2001a). However,
since approximately half of the BXD-8 genome is derived
from the DBA/2 strain, it was not clear whether any DBA/2
alleles had an epistatic genetic effect on its increased
susceptibility. Transgenic expression of a bacterial artificial
chromosome containing the C57BL/6 allele of Ly49h into
the susceptible BALB/c genetic background also conferred
resistance to MCMV (Lee et al. 2003), but it remained
possible that other background BALB/c alleles may modify
the Ly49h effect.
To further analyze the role of Ly49h in NK cell function,
particularly in infections, we backcrossed the BXD-8 RI
strain onto C57BL/6 strain by marker-assisted backcrossing
(speed congenics). We termed this novel strain B6.BXD8-
Klra8Cmv1-del/Wum, referred to by the shorthand of B6.
BXD8 in this paper, and characterized the NK cell function
of this strain.
Materials and methods
Animals C57BL/6NCR mice were purchased from National
Cancer Institute. The RI strain BXD-8 was purchased from
The Jackson Laboratory (Bar Harbor, ME, USA) and was
backcrossed to C57BL/6 for nine generations to generate
the novel strain B6.BXD8-Klra8Cmv1-del/Wum. At each
successive generation, heterozygous pups carrying the
deleted Ly49h allele were identified by flow cytometry.
Microsatellite genotyping was performed by the Speed
Congenics Core of the Rheumatic Diseases Core Center at
Washington University to screen for C57BL/6 markers for
the initial seven generations. Subsequently, two more
generations were backcrossed onto C57BL/6 while follow-
ing the heterozygous expression of Ly49H phenotype by
flow cytometry. All animals were maintained in a specific
pathogen-free facility at Washington University School of
Medicine, and all experiments were approved by the
Animal Studies Committee.
Southern analysis Genomic DNA for BXD-8 was pur-
chased from Jackson Laboratory. Splenic genomic DNA for
C57BL/6 and B6.BXD8 were extracted using Gene Pure
following manufacturer’s protocol. Digested DNA was
separated on a 1% agarose gel and transferred onto a
nitrocellulose membrane. Membrane was subsequently
hybridized with the BglII–PstI fragment of Ly49H comple-
mentary DNA (cDNA) labeled with 32αP-dCTP using
Rediprime II System (Amersham, UK) following the
manufacturer’s protocol and image acquired using the
Typhoon system (Amersham).
Plaque assays Viral titers were quantified using methods
previously published (French et al. 2004). Briefly, whole
spleens were harvested and frozen in 1 ml aliquots of D10
[Dulbecco’s modified Eagle’s medium supplemented with
10% newborn calf serum (Hyclone), 100 U/ml penicillin,
100 μg/ml streptomycin and 2 mM glutamine]. Liver
sections were weighed in 1 ml aliquots of D10 medium.
Tissues were subsequently thawed, homogenized via
dounce homogenizers, and used to infect NIH-3T12
fibroblast monolayers in triplicates in six-well plates.
Titers were calculated as log(PFU/spleen) or log(PFU/
100 mg of liver).
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Flow cytometric analysis of natural killer cells Single-cell
suspensions were prepared from spleens as previously
described (French et al. 2004). Splenocytes were stained
with APC-PK136 (NK1.1), PerCP-Cy5.5-2C11 (CD3), and
PerCP-Cy5.5-1D3 (CD19) in supernatant produced by
2.4G2 hybridoma to block FcRII/III. The following anti-
bodies were used to identify respective cell surface
markers: PE-eBio12AB (Ly49A/D), PE-5E6 (Ly49C/I),
FITC-4E4 (Ly49D), FITC-3D10 (Ly49H), PE-16a11
(NKG2AB6), and PE-CX5 (NKG2D). Except for the
Ly49H antibody, which was made in-house, the other
antibodies were purchased from BD Biosciences (San Jose,
CA, USA). For intracellular IFN-γ staining, cells were
permeabilized with Cytofix/Cytoperm (PharMingen, La
Jolla, CA, USA) per manufacturer’s protocol and stained
with PE-conjugated anti-IFN-γ (clone XMG1.2) purchased
from BD Biosciences. To evaluate BrdU incorporation,
each mouse was injected with 2 mg of BrdU intra-
peritoneally 3 h prior to spleen harvest. Splenocytes were
stained with surface markers and then permeabilized using
Cytofix/Cytoperm following the manufacturer’s protocol.
Intracellular BrdU was determined by staining with FITC-
anti-BrdU antibody (BD Biosciences) as previously de-
scribed (Dokun et al. 2001).
Quantitative RT-PCR Total RNA was extracted from
spleens using Trizol (Invitrogen, Carlsbad, CA, USA).
cDNA was subsequently generated using oligo-dT primers
while following the protocol for Superscript III First Strand
Synthesis (Invitrogen). PCR primers for Ly49D were:
forward 5′-TTCAGGGTTGCAGAACGAGATGAG-3′; re-
verse 5′-AGGATCCCGAGAGCTATCACAATG-3′. The
internal probe sequence was 5′-AAAGCTCGCCTCA




CATTGT-3′. Messenger RNA (mRNA) expression was
normalized against β-actin expression and then compared
to levels expressed in C57BL/6 splenocytes.
Results
Analysis of 110 microsatellite markers polymorphic be-
tween C57BL/6 and DBA/2 revealed that whereas the
original recombinant inbred strain BXD-8 carried 52% of
C57BL/6-derived genome, B6.BXD8 demonstrated 100%
of C57BL/6-derived genome except for Ly49h (Fig. 1).
Previous study from our laboratory demonstrated that
BXD-8 carried a genomic deletion at the Ly49h locus in
the midst of a chromosomal segment derived from C57BL/
6 (Brown et al. 2001a, b). Southern analysis of B6.BXD8
genomic DNA digested with BglII and EcoRI, when
hybridized with the 177-bp BglII–PstI fragment of Ly49h
cDNA, revealed the same patterns as those of BXD-
8 genome (data not shown). The absence of a 3.5-kb band
in B6.BXD8 in the BglII digest likely represented the
genomic locus 82385903 to 82389340 in the C57BL/6
reference sequence (GeneBank accession number
Mm6_39393_37). Furthermore, the absence of a 5-kb band
in B6.BXD8 in the EcoRI digest likely represented the
genomic locus 82385831 to 82390624 in C57BL/6. The
exact junctions where this deletion occurred, however, was
difficult to define given the high degree of sequence
homology amongst Ly49 family members and the frequen-
cy of repeat sequences in this region. Repeated attempts to
amplify genomic sequences in this region with PCR
suggested that B6.BXD8 contained minimally a 20-kb
genomic deletion spanning Ly49h, including the exon
encoding the first start codon for Ly49h (data not shown).
Consistent with this idea was the absence of detectable
Ly49H mRNA by quantitative reverse transcription poly-
merase chain reaction (RT-PCR; Fig. 2a). Moreover,
mRNA expression level of Ly49d, the gene immediately
Fig. 1 Microsatellite genotyping analysis of B6.BXD8 strain. Numb-
ers below microsatellite markers denote the distance of markers in
centiMorgans according to the WI-Genetic Map (Hudson et al. 2001).
Black boxes denote C57BL/6 alleles, whereas white boxes indicate
DBA/2 alleles. One shaded box (Chr 13) denotes a mixed-marker type
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proximal to Ly49h in the NKC, was similar between
C57BL/6 and B6.BXD8. Taken together, these data
demonstrate that B6.BXD8 preserved the genomic Ly49h
deletion from the original recombinant inbred strain BXD-
8, while the rest of the genome is derived from C57BL/6.
At the protein level, flow cytometric analysis of NK cells
from B6.BXD8 demonstrated no detectable surface staining
with the anti-Ly49H-specific 3D10 monoclonal antibody as
compared to 40% of NK cells from C57BL/6 (Fig. 2b, left
panel). On the other hand, both C57BL/6 and B6.BXD8
NK cells expressed comparable levels of NK1.1, an NK
cell-specific marker encoded by Nkrp1c in the neighboring
NKC, adjacent to the Ly49 locus. Furthermore, other
receptors encoded in the NKC, such as Nkrp1d and
NKG2D, were also expressed at similar levels in C57BL/
6 and B6.BXD8 (Fig. 3a). Finally, both B6.BXD8 and
C57BL/6 NK cells expressed comparable levels of other
Ly49 family members, Ly49A/D, Ly49D, Ly49C/I, and
Ly49G (Fig. 3a), further supporting that B6.BXD8 specif-
ically lacks Ly49H expression while demonstrating intact
expression of known NKC surface receptors.
Further characterization of NK cells from B6.BXD8
mice demonstrated comparable levels of the maturation
marker, Mac-1, as NK cells from C57BL/6 (Fig. 2b, middle
panel). Inasmuch as Mac-1 is expressed on functionally
mature NK cells, these data suggest full functional
maturation of B6.BXD8 NK cells. Indeed, both B6.BXD8
and C57BL/6 NK cells produced similar levels of IFN-γ
after NK1.1 activation (Fig. 3b). Thus, B6.BXD8 NK cells
do not have any gross defect in IFN-γ production.
Fig. 2 Absence of Ly49h expression in B6.BXD8. a mRNA
expression of Ly49H in C57BL/6 and B6.BXD8. As determined
by quantitative RT-PCR, the relative expression represents ratios of
Ly49D or Ly49H mRNA expression in B6.BXD8 splenocytes,
normalized by β-actin, compared to those in C57BL/6 splenocytes.
These results are representative of two independent experiments. b
Flow cytometric analysis of C57BL/6 and B6.BXD8 NK cells. Fresh
splenocytes were labeled with a combination of anti-CD3, CD19,
and NK1.1 antibodies in the presence of 2.4G2 hybridoma
supernatant to block non-specific FcγRII/III binding. NK cell gate
was defined as CD3-/CD19−/NK1.1+. The dashed lines represent NK
cells from C57BL/6, while the solid shaded curves represent B6.
BXD8. These results are representative of a minimum of two inde-
pendent experiments
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Fig. 3 Normal NKC receptor expression and function of NK cells in
B6.BXD8. a Cell surface expression of NKC ligands on C57BL/6 and
B6.BXD8 NK cells. The dashed lines represent NK cells from C57BL/
6, while the solid shaded curves represent B6.BXD8. For the NKG2D
staining, the dotted unshaded curve represents staining with the
isotype control. Results were representative of two independent
experiments. b NK cell activation after NK1.1 activation in vitro.
Freshly isolated splenocytes were plated in six-well plates coated with
PK136 (anti-NK1.1 monoclonal antibody) at 5 μg/well for 7 h in the
presence of GolgiPlug (BD). Cells were subsequently permeabilized
and intracellular IFN-γ expression analyzed following manufacturer’s
protocol (BD Biosciences). These results were representative of two
independent experiments
Immunogenetics (2008) 60:565–573 569
Fig. 4 MCMV infection in B6.BXD8. a Splenic and liver MCMV
viral titers in C57BL/6 and B6.BXD8 mice. Each mouse was infected
with 5×104 PFU of Smith strain MCMV intraperitoneally, and spleens
and livers were harvested on day 3 post-infection. MCMV viral titers
were quantified using methods described previously. b IFN-γ
production in C57BL/6 and B6.BXD8 NK cells after MCMV
infection. Mice were infected with 5×104 PFU of MCMV intra-
peritoneally, and spleens were harvested at 38 hours post-infection.
Intracellular IFN-γ staining was performed on freshly isolated
splenocytes following the manufacturer’s protocol. The results shown
were gated on the total NK cell population (CD3−/CD19−/NK1.1+).
The upper two panels show isotype controls for anti-IFN-γ antibody.
The middle two panels are NK cells from mock-infected mice. The
lowest two panels show NK cells after MCMV infection. This result is
representative of two independent experiments. c NK cell proliferation
after MCMV infection. C57BL/6 and B6.BXD8 mice were infected
with 5×104 PFU of MCMV and spleens harvested on day 2 post-
infection. Three hours prior to splenocyte harvest, each mouse was
intraperitoneally injected with 2 mg of BrdU, and subsequent
intracellular BrdU staining was performed following the manufac-
turer’s protocol. The histograms display total NK cell populations,
defined as CD3−/CD19−/NK1.1+. The shaded curves denote unstained
controls, while the dotted lines denote cells stained with anti-Brdu
antibody. The percentages of cells positive for anti-BrdU are
quantified in the gates
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We next sought to further delineate the MHC-indepen-
dent contribution of Ly49H in controlling MCMV infec-
tion. We measured splenic and liver viral titers after
intraperitoneally infecting both C57BL/6 and B6.BXD8
mice with Smith strain MCMV (Fig. 4a). Indeed, at day 3
post-MCMV infection, the splenic titers from B6.BXD8
mice were nearly two logs higher than those of C57BL/6
(mean log titers for C57BL/6 and B6.BXD8 were 3.5 and
5.3 PFU/spleen, respectively, p<0.0001 by unpaired t test).
Moreover, consistent with previous findings (Brown et al.
2001a), a small but statistically significant difference was
found between hepatic viral titers between C57BL/6 and
B6.BXD8 on day 3 post-infection (p=0.0046 by unpaired t
test). After infection with Smith strain MCMV, B6.BXD8
mice demonstrated a LD50 of 7×10
4 PFU, approximately
threefold less than that for C57BL/6 (data not shown).
Thus, these data indicate that Ly49h plays a significant role
in C57BL/6 in controlling MCMV infection and rule out
any epistatic effect by DBA/2 alleles in BXD-8.
During MCMV infection, we previously reported that
NK cells are both non-specifically and specifically acti-
vated when considering Ly49H expression (Dokun et al.
2001). However, it was not clear if specific activation of
NK cells through Ly49H contributed to non-specific
activation. When we infected B6.BXD8 mice with MCMV,
we found that B6.BXD8 NK cells express IFN-γ at similar
levels as those of C57BL/6 NK cells at 38 hours post-
MCMV infection (Fig. 4b). This finding indicated that the
early, non-specific IFN-γ production occurs normally
during MCMV infection in the absence of Ly49h. Another
non-specific effect is the stimulation of NK cell prolifera-
tion early during MCMV infection. We observed no
difference in the incorporation of BrdU in C57BL/6 versus
B6.BXD8 splenocytes at 38 hours after MCMV infection
(Fig. 4c). Thus, the “non-specific” (with respect to Ly49H
expression) activation of NK cells does not require
triggering through Ly49H itself (Dokun et al. 2001).
Previous genetic studies mapped the resistance to two
other DNA viruses, HSV-1 and ectromelia virus, to NKC,
but genes for host resistance have not been further
elucidated (Brown et al. 2001a; Delano and Brownstein
1995). We thus sought to evaluate whether the deletion of
Ly49h on the C57BL/6 background altered host suscepti-
bility to these viral infections. At both high and low doses
of intraperitoneal HSV-1 infection, B6.BXD8 mice demon-
strated similar rates of survival as C57BL/6 (Fig. 5).
Similarly, infection with ectromelia virus resulted in
comparable viral titers in C57BL/6 and B6.BXD8 mice
on days 5, 6, and 7 post-infection as measured by
quantitative PCR from two independent experiments (data
not shown). Together, these data suggest that Ly49h does
not account for NKC-linked genetic resistance to HSV or
ectromelia virus infections.
Discussion
Natural killer cells play important roles in controlling viral
infections, and how NK cells are able to recognize and
control diverse viral pathogens with a limited repertoire of
innate receptors is still poorly defined. In the case of
C57BL/6 mice and control of MCMV viremia, we show
here that the deletion of a single NK cell receptor, namely
Ly49h, in the C57BL/6 genetic background greatly
increased host susceptibility. This current paper further
extends previous findings that Ly49H, a single NK
activation receptor, plays a critical role in the control of
MCMV infection in C57BL/6 mice because the present
data exclude any epistatic genetic effect of DBA/2 alleles
in the phenotype of BXD-8 mice. Taken together with
previous work (Brown et al. 2001b; Lee et al. 2001,
2003), these data provide strong genetic evidence that
Ly49h plays a major role in the ability of C57BL/6 mice to
resist MCMV infection.
Although we were not able to pinpoint the genetic lesion
in B6.BXD8, our novel strain demonstrated a specific
deficiency of Ly49H at the protein level but intact
expression of other examined receptors in the NKC region.
Ly49n and Ly49k, two loci juxtaposing Ly49h, were
previously identified as pseudogenes (McQueen et al.
1999). Their presence or absence is thus unlikely to account
for the increased susceptibility of B6.BXD8 to MCMV, as
Fig. 5 Survival curves of
C57BL/6 and B6.BXD8 mice
after HSV infection. Mice were
intraperitoneally inoculated with
either low dose (3×106 PFU) or
high dose (3×107 PFU) of strain
17 HSV-1. Mice were observed
for survival for 22 days
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compared to C57BL/6. Furthermore, while it is theoretical-
ly plausible that DBA/2 genes could have recombined into
the Ly49h region in B6.BXD8 during the recombinant
inbreeding process, this is very unlikely because a double
crossover event would be needed in a very tight region.
Regardless, B6.BXD8 has a specific Ly49h deletion on the
C57BL/6 genetic background.
Interestingly, we previously detected non-stochastic
expression of Ly49H with Ly49D on NK cells in normal
B6 mice (Smith et al. 2000). These activation receptors
both signal through the DAP12 signaling chain. One
possible explanation for their co-expression is their inter-
dependent transcriptional regulation. However, our current
studies indicate that the absence of Ly49h did not appear to
affect Ly49D expression, indicating that Ly49D expression
is independent of Ly49H expression, raising the possibility
that their tendency to be expressed with each other in
normal mice may be related to their common requirement
for DAP12.
Our current study found no gross defect with NK cell
maturation markers, expression of other NKC-encoded
receptors, or NK cell function in B6.BXD8 mice, indicating
that Ly49H is not necessary for NK cell development.
Importantly, unlike other Ly49 members which interact
with host MHC class I molecules and modulate NK
activation, Ly49H has no known endogenous ligand.
Whether Ly49H plays roles other than antiviral protection
against MCMV remains to be determined, and it is possible
that Ly49H enables NK cells to recognize pathogens other
than MCMV. However, in our current study, we found that
B6.BXD8 and C57BL/6 mice are equally susceptible to
HSV-1 and ectromelia virus, two pathogens whose resis-
tance is encoded in the NKC region.
Our previous studies indicated that NK cells appear to
undergo two phases of activation during MCMV infection,
an early (days 1–2) “non-specific” (independent of Ly49H
expression) and a later (days 3–6) “specific” phase whereby
Ly49H+ NK cells undergo selective proliferation (Dokun et
al. 2001). However, it was not clear if triggering through
Ly49H itself contributed to the non-specific phase. Herein,
we found that NK cells in B6.BXD8 mice have no defect in
their non-specific responses, indicating that Ly49h is
dispensable for early non-specific NK cell stimulation
during MCMV infections.
Given the importance of Ly49 family in modulating NK
cell functions, the novel strain B6.BXD8 may serve as a
useful tool for further delineation of NK activation
receptors. Previously, functional analysis of Ly49 activation
receptors were derived from examining mice deficient or
defective in the adaptor molecule DAP12, since activation
Ly49 receptors do not contain intrinsic signaling motifs and
signal downstream by association with the DAP12 adaptor
molecule (Bakker et al. 2000; Kaifu et al. 2003; Smith et al.
1998). However, DAP12 can also associate with other
activation receptors and is expressed in several different
cell types (Bouchon et al. 2001), indicating that DAP12-
deficient mice have broader defects. Therefore, B6.BXD8
will allow the evaluation of the endogenous function
of Ly49H and indirectly other activation receptors with
more precision.
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